Effect of Anfei Yishen Formula on Lung Function in Rats with Chronic Obstructive Pulmonary Disease

WU Jianjun1; JIANG Liangduo2; LU Xiangfeng2; ZHANG Xiaomei3; ZHANG Wei4; PANG Baosen5

doi:10.13288/j.11-2166/r.2012.17.016

您当前的位置：

首页 >

文章列表页 >

Effect of Anfei Yishen Formula on Lung Function in Rats with Chronic Obstructive Pulmonary Disease

更新时间：2021-11-17

- Effect of Anfei Yishen Formula on Lung Function in Rats with Chronic Obstructive Pulmonary Disease
- Journal of Traditional Chinese Medicine Vol. 53, Issue 17, Pages: 1492-1494(2012)
- 作者机构：
  
  1. 北京中医药大学第三附属医院
  2. 北京中医药大学东直门医院
  3. 北京中医药大学东方医院
  4. 首都医科大学附属北京地坛医院
  5. 首都医科大学附属北京朝阳医院北京呼吸疾病研究所
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2012.17.016
  CLC： R259
- Published：2012
- 稿件说明：
移动端阅览
[1]吴建军,姜良铎,鲁香凤,张晓梅,张伟,庞宝森.安肺益肾方对慢性阻塞性肺疾病模型大鼠肺功能的影响[J].中医杂志,2012,53(17):1492-1494+1498.

WU Jianjun1, JIANG Liangduo2, LU Xiangfeng2, et al. Effect of Anfei Yishen Formula on Lung Function in Rats with Chronic Obstructive Pulmonary Disease[J]. Journal of Traditional Chinese Medicine2012, 53(17): 1492-1494.
[1]吴建军,姜良铎,鲁香凤,张晓梅,张伟,庞宝森.安肺益肾方对慢性阻塞性肺疾病模型大鼠肺功能的影响[J].中医杂志,2012,53(17):1492-1494+1498. DOI： 10.13288/j.11-2166/r.2012.17.016.

WU Jianjun1, JIANG Liangduo2, LU Xiangfeng2, et al. Effect of Anfei Yishen Formula on Lung Function in Rats with Chronic Obstructive Pulmonary Disease[J]. Journal of Traditional Chinese Medicine2012, 53(17): 1492-1494. DOI： 10.13288/j.11-2166/r.2012.17.016.

摘要

目的观察安肺益肾方对慢性阻塞性肺疾病（COPD）大鼠肺功能和肺组织损伤的干预作用。方法健康Wistar大鼠72只

采用随机数字表法分为安肺益肾方大、中、小剂量组

氨茶碱组、模型组、正常对照组

每组12只

除正常对照组外

其余各组大鼠采用熏香烟加气管注入内毒素法建立COPD大鼠模型。造模成功后

安肺益肾方大、中、小剂量组分别给予生药2.4、1.2、0.6g/kg;氨茶碱组给药15mg/kg;模型组和正常对照组灌胃等量0.5%羧甲基纤维素溶液;每天灌胃1次

连续4周。各组随机取8只大鼠

测定肺功能

包括第0.2s用力呼气量（FEV0.2）、第0.2s用力呼气量与用力肺活量比值（FEV0.2/FVC）及呼气阻力（Re）、吸气阻力（Ri）;取大鼠右肺HE染色

观察各组大鼠肺组织病理变化。结果与正常对照组比较

模型组FEV0.2/FVC、FEV0.2显著降低

Re、Ri显著升高（P<0.01）。与模型组比较

安肺益肾方大、中、小剂量组、氨茶碱组均能显著提高FEV0.2/FVC

降低Re（P<0.01）;安肺益肾方大剂量组提高FEV0.2（P<0.05）;安肺益肾方中剂量组提高FEV0.2

降低Re（P<0.01）;安肺益肾方中剂量组FEV0.2/FVC高于安肺益肾方大、小剂量组

FEV0.2高于小剂量组（P<0.05）

Re、Ri低于安肺益肾方大、小剂量组。安肺益肾方能减轻COPD模型大鼠肺组织病理炎性浸润

减少肺大泡的形成。结论安肺益肾方能改善COPD模型大鼠的肺功能

改善模型大鼠肺组织损伤。

Abstract

Objective To observe the effect of Anfei Yishen Formula Lung-Quieting Kidney-Boosting Formula on pulmonary function and tissue injury in chronic obstructive pulmonary disease（COPD） rats.Methods Seventy-two healthy Wistar rats were randomized into Formula large

medium and small-dose groups

aminophylline group

model group and normal control group

with 12 in each.The COPD models were induced by intratracheal instillation of lipopolysaccharide and passive smoking.The rats in Formula large

medium and small-dose groups were intragastrically administered with Anfei Yishen Formula（crude drug 2.4g/kg

1.2g/kg and 0.6g/kg respectively）.The rats in aminophylline group were administered with 15mg/kg of aminophylline.The rats in model group and normal control group were administered with 0.5% of sodium carboxymethyl cellulose.The intragastric administration lasted for four weeks.Eight rats in each group were randomly selected to detect the pulmonary function such as forced expiratory volume in 0.2s（FEV0.2）

FEV0.2-to-forced vital capacity（FVC） ratio（FEV0.2/FVC

%）

expiratory resistance（Re） and inspiratory resistance（Ri）.The pathological changes in lung tissue of the rats were observed under HE staining.Results Comparing with the normal control group

FEV0.2 and FEV0.2/FVC significantly decreased and Re and Ri significantly increased in the model group（P<0.01）.Comparing with the model group

FEV0.2/FVC significantly increased and Re significantly decreased in Formula large

medium and small-dose groups（P<0.01）.FEV0.2 significantly increased in Formula large group（P<0.05）.FEV0.2 significantly increased and Re significantly decreased in Formula medium group（P<0.05 or P<0.01）.FEV0.2/FVC was higher and Re and Ri were lower in the Formula middle-dose group than in large and small dose group and the level of FEV0.2 was higher than that of the small-dose group.Anfei Yishen Formula could relieve the pathological inflammatory infiltration and reduce the formation of bullae in COPD rat lung tissue.Conclusion Anfei Yishen Formula could improve the pulmonary function and relieve the pathological changes of lung tissue in COPD rats.

关键词

Keywords

references

查看原文

Views

224

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Observation on 45 Cases of Chronic Obstructive Pulmonary Disease in the Stable Phase with Qi Deficiency，Blood Stasis and Phlegm Obstruction Syndrome with Auxiliary Treated with Jinwei Guben Decoction （金卫固本汤） Combined with Bailing Capsule （百令胶囊）

Effect of Zhoufei Dingchuan Ointment （皱肺定喘膏） Combined with Conventional Western Medicine on Pulmonary Function of Patients with Stable Chronic Obstructive Pulmonary Disease of Lung-kidney Deficiency Pattern

Clinical Observation on Qi-Boosting Spleen-Fortifying Granules Combined with Western Medicine for 60 Cases of Stable Chronic Obstructive Pulmonary Disease with Lung-Spleen Qi Deficiency Pattern

Clinical Observation on 44 Chronic Obstructive Pulmonary Disease at Stable Phase Treated with Acupoint Heat Sensitization Moxibustion

Huanglong Kechuan Capsule（黄龙咳喘胶囊） for Stable Chronic Obstructive Pulmonary Disease with Lungkidney Qi Deficiency and Phlegm-heat Constraint in the Lung Syndrome: A Multiple-centered,Randomized,Placebo-controlled,Double-blind Trial of 160 Cases

Related Author

KONG Deyu

ZHENG Xudong

ZHOU Huimin

WANG Ruitao

ZHAO Benzhang

WU Jianjun

Song YU

Mingzhi PU

Related Institution

Beijing University of Chinese Medicine Third Affiliated Hospital

Suzhou Hospital of Traditional Chinese Medicine

The First Affiliated Hospital of Zhejiang Chinese Medical University

TCM Hospital of Hangzhou

Integrative Medicine Hospital of Zhejiang

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰